Global Oncology Devices Research Report 2023: Enhanced Treatment Options Propels Growth – Analysis by Device Type (Ablation, Embolization), & Cancer Type (Breast, Uterine, Colon and Rectum, Prostate) – ResearchAndMarkets.com

The “Global Oncology Devices Market (2023 Edition): Analysis By Device Type (Ablation, Embolization, Others), Cancer Type (Breast, Uterine, Colon and Rectum, Prostate, Others), By Application, By Region, By Country: Drivers, Trends and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The Global Oncology Devices Market is expected to generate 217.00 billion by the end of 2029, up from USD 69.80 Billion in 2022. During the forecast period, 2024-2029, the Global Oncology Devices market is expected to grow at a CAGR of 18.05%.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Italy, Spain, China, India, Japan). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The oncology devices market is comprised of a vast assortment of medical devices used for the detection, treatment, and management of cancer. These devices include imaging devices, biopsy devices, radiation therapy devices, surgical devices, and more. As cancer remains a leading cause of mortality and morbidity across the globe, there has been an increase in demand for oncology devices.

The primary driver of the Oncology Devices market is the rising incidence of cancer worldwide, which is primarily attributable to an aging population, sedentary lifestyles, environmental factors, and genetic predisposition. Increasing cancer awareness and early detection measures have resulted in higher cancer screening rates. This has increased the demand for oncology devices used for early cancer detection and staging.

Moreover, accelerated technological developments have transformed the diagnosis and therapy of cancer. Novel medical devices, such as molecular testing, targeted treatments, and immunotherapies, which have improved outcomes for patients and expanded treatment options, which is driving market growth.

Strategic Recommendations

  • Robot-assisted surgery devices for Cancer
  • Adoption of improved reimbursement policies to support the demand of Oncology devices market

Report Highlights

  • Impact Analysis of Macro Economic Factors on Oncology Devices Market
  • PET/CT price in Select countries, In EUR
  • Radiation therapy price, in Select Countries, in EUR
  • Radiofrequency ablation prices, in Select Countries, in EUR
  • Age-standardised cancer incidence rate, 2020
  • Oncology Devices in Pipeline
  • Global Oncology Devices Market: Dashboard
  • Global Oncology Devices Market: Market Value Assessment, 2019-2029 (USD Billion)
  • Impact of COVID-19 on Global Oncology Devices Market

Global Oncology Devices Market Historic and Forecast (2019-2029)

Global Oncology Devices Market Segmentation: By Device Type

  • Global Oncology Devices Market, By Device Type Overview
  • Global Oncology Devices Market Size, By Ablation Devices, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Embolization devices, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Other Devices, By Value, 2019H-2029F (USD Billion & CAGR)

Global Oncology Devices Market Segmentation: By Cancer Type

  • Global Oncology Devices Market, By Cancer Type Overview
  • Global Oncology Devices Market Size, By Breast cancer, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Uterine cancer, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Colon and rectum cancer, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Prostate cancer, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Other Cancer Types, By Value, 2019H-2029F (USD Billion & CAGR)

Global Oncology Devices Market Segmentation: By Application

  • Global Oncology Devices Market, By Application Overview
  • Global Oncology Devices Market Size, By Chemotherapy, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Radiation, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Surgical, By Value, 2019H-2029F (USD Billion & CAGR)
  • Global Oncology Devices Market Size, By Diagnosis, By Value, 2019H-2029F (USD Billion & CAGR)

Competitive Positioning

  • Companies’ Product Positioning
  • Market Position Matrix
  • Market Share Analysis of Oncology Devices Market

Company Profiles

  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • GE HealthCare Technologies Inc
  • Elekta AB
  • Medtronic PLC
  • BEBIG Medical GmbH
  • Theragenics Corporation

For more information about this report visit https://www.researchandmarkets.com/r/l26psq

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version